Veminsyn

Private

BeijingHealthcare & Life Scienceshttps://veminsyn.com/

Last Round

Series B

Extension

Sep 29, 2025

Est. Valuation

$100M

Total Funding Raised

$37.02M

Company Overview

Veminsyn is a biotechnology company that specializes in the research, development, and production of bio-based active ingredients for the personal care, cosmetics, and medical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Fashion & Beauty, Smart Manufacturing

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

synthetic biologybioactive ingredientsCRDMOcontract research development and manufacturingbio-manufacturingsynbioAI-driven drug discoverycellular digital twinsbiotech platformcosmetic ingredientsmolecular simulationplant cell manufacturingbiotech foundryskincare innovationbio-based materials

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Veminsyn Comps

Public and private peers based on sector, stage, and business model.

Veminsyn comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Veminsyn Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series B Extension	Sep 29, 2025
Corporate Funding	May 23, 2025
Series A	Oct 18, 2022
Angel	Nov 1, 2021
Pre Seed	Nov 1, 2021

View all Funding Rounds

Veminsyn Investors

Notable investors and investment history

Veminsyn investors
Investor	Rounds
CITIC Capital	Series A
ZhenFund	Pre Seed, Series A, Angel
Hony Capital	Series A, Pre Seed
BOLD (Business Opportunities for L'Oréal Development)	Corporate Funding
Zhejiang Haibang Private Equity Fund Management Co., Ltd.	Series B Extension

View all Investors

Veminsyn Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Veminsyn Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Veminsyn's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing

Employee Range2

Year Founded2021

Last FundingSep 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.